Your browser doesn't support javascript.
loading
Value of Information Analysis for Research Decisions-An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.
Fenwick, Elisabeth; Steuten, Lotte; Knies, Saskia; Ghabri, Salah; Basu, Anirban; Murray, James F; Koffijberg, Hendrik Erik; Strong, Mark; Sanders Schmidler, Gillian D; Rothery, Claire.
Afiliação
  • Fenwick E; Pharmerit International, Oxford, England, UK. Electronic address: efenwick@pharmerit.com.
  • Steuten L; Office of Health Economics, London, England, UK.
  • Knies S; National Health Care Institute (Zorginstituut Nederland), Diemen, The Netherlands.
  • Ghabri S; French National Authority for Health, Paris, France.
  • Basu A; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle, WA, USA.
  • Murray JF; Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Indianapolis, IN, USA.
  • Koffijberg HE; Department of Health Technology & Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands.
  • Strong M; School of Health and Related Research, University of Sheffield, Sheffield, England, UK.
  • Sanders Schmidler GD; Duke-Margolis Center for Health Policy, Duke Clinical Research Institute and Department of Population Health Sciences, Duke University, Durham, NC, USA.
  • Rothery C; Centre for Health Economics, University of York, York, England, UK.
Value Health ; 23(2): 139-150, 2020 02.
Article em En | MEDLINE | ID: mdl-32113617
ABSTRACT
Healthcare resource allocation decisions made under conditions of uncertainty may turn out to be suboptimal. In a resource constrained system in which there is a fixed budget, these suboptimal decisions will result in health loss. Consequently, there may be value in reducing uncertainty, through the collection of new evidence, to make better resource allocation decisions. This value can be quantified using a value of information (VOI) analysis. This report, from the ISPOR VOI Task Force, introduces VOI analysis, defines key concepts and terminology, and outlines the role of VOI for supporting decision making, including the steps involved in undertaking and interpreting VOI analyses. The report is specifically aimed at those tasked with making decisions about the adoption of healthcare or the funding of healthcare research. The report provides a number of recommendations for good practice when planning, undertaking, or reviewing the results of VOI analyses.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Avaliação da Tecnologia Biomédica / Orçamentos / Alocação de Recursos para a Atenção à Saúde / Técnicas de Apoio para a Decisão / Custos de Medicamentos / Tomada de Decisões / Desenvolvimento de Medicamentos / Pesquisa sobre Serviços de Saúde Tipo de estudo: Guideline / Health_economic_evaluation / Health_technology_assessment / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Value Health Assunto da revista: FARMACOLOGIA Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Avaliação da Tecnologia Biomédica / Orçamentos / Alocação de Recursos para a Atenção à Saúde / Técnicas de Apoio para a Decisão / Custos de Medicamentos / Tomada de Decisões / Desenvolvimento de Medicamentos / Pesquisa sobre Serviços de Saúde Tipo de estudo: Guideline / Health_economic_evaluation / Health_technology_assessment / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Value Health Assunto da revista: FARMACOLOGIA Ano de publicação: 2020 Tipo de documento: Article